This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Billingham, L J Articles by Abrams, K R Search for Related Content PubMed PubMed Citation Articles by Billingham, L J Articles by Abrams, K R Social Bookmarking                         What's this?

Simultaneous analysis of quality of life and survival data

Cancer Research Campaign Trials Unit, Institute for Cancer Studies, The Medical School, University of Birmingham, Birmingham, UK

K R Abrams

Department of Epidemiology and Public Health, University of Leicester, Leicester, UK

In many phase III clinical trials, particularly in the field of cancer, the comparison of treatments is based on both length of survival and quality of life. Subjects are followed over time until death and during this period, quality of life is assessed on a number of occasions. Simultaneous analysis of these two outcomes supplements the comparison of treatments in terms of each outcome independently with an assessment of the net effect. In addition, it provides a means of accounting for the informative dropout due to death of patients within the time frame of the quality of life study. The methods also have the potential to be extended to allow for informative dropout from the quality of life study prior to death. There are a number of broad approaches for the simultaneous analysis of quality of life and survival data. The most widely used approach in clinical research is quality-adjusted survival analysis, where treatments are compared in terms of a composite measure of quality and quantity of life. The paper reviews the different techniques for quality-adjusted survival analysis, illustrating the methodology by application to data from a phase III clinical trial in pancreatic cancer. In addition, alternative approaches using multistate survival analysis and joint modelling methods are also discussed.

Statistical Methods in Medical Research, Vol. 11, No. 1, 25-48 (2002)
DOI: 10.1191/0962280202sm269ra


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. J. Lee, B. N. Bekele, X. Zhou, S. B. Cantor, R. Komaki, and J. S. Lee Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer J. Clin. Oncol., August 1, 2006; 24(22): 3597 - 3603. [Abstract] [Full Text] [PDF]

				P Del Bianco and R Borgoni Handling dropout and clustering in longitudinal multicentre clinical trials Statistical Modeling, July 1, 2006; 6(2): 141 - 157. [Abstract] [PDF]

				B Jones Implications of quality adjusted survival for clinical trials in radiation oncology. Br. J. Radiol., April 1, 2006; 79(940): 353 - 355. [Abstract] [Full Text] [PDF]